Redcare Pharmacy Logo
NL0012044747
A2AR94
SAE.MU

Redcare Pharmacy

Chargement des cours...

Prévisions

Acheter
  1
Conserver
  0
Vendre
  0

Discussions dans la communauté

Il n'y a pas encore de discussion sur cet actif.

Lancer une discussion

  • Redcare Pharmacy reaches over 15 million active customers and high customer retention

    Redcare Pharmacy reports more than 15 million active customers who ordered at least once in the past twelve months, and a reorder rate above 90 percent in the third quarter of 2026. The company still sees significant growth potential, particularly from the introduction of the e-prescription in Germany, where the online share of prescription drugs is currently only around two percent. Compared with countries like Sweden, which have much higher online penetration, the investment story remains attractive over the long term. » Plus sur deraktionaer.de


  • Redcare Pharmacy: analysts raise price targets after Q3 data and see substantial upside potential

    Redcare Pharmacy benefits from stronger demand for electronic prescriptions and prescription drugs, prompting an upward revision of forecasts. Detailed Q3 figures confirmed analysts' optimism; Berenberg sets a price target of €102, Metzler raised its target to €145 and MPCM/Siering to €125. Siering increased EBIT forecasts but lowered the EPS rating and partly attributes the higher price target to accounting for the convertible bond as debt. The stock showed relative strength in a volatile market and attracted buyers after a pullback. » Plus sur deraktionaer.de


  • Redcare Pharmacy grows strongly thanks to e-prescriptions in Germany

    Redcare Pharmacy is benefiting from the e-prescription boom: in the third quarter revenue rose 18% to €847 million, and sales of prescription medicines in Germany climbed 56% to €197 million. Adjusted EBITDA increased 68% to €28.7 million, the adjusted operating margin was 3.4%, and the group swung to an annual profit of €1 million (previous year: -€7 million). Management confirmed the full-year targets and expects 16–18% revenue growth for 2026 with an adjusted EBITDA margin of 2.5–3.0%. After the strong share-price rally, the stock came under short-term pressure from profit-taking. » Plus sur finanzen.net


  • Redcare Pharmacy benefits from e-prescription boom, shares fall after profit-taking

    Redcare Pharmacy increased sales in the third quarter by 18% to €847 million and adjusted EBITDA by 68% to €28.7 million, slightly beating expectations. Despite the positive results, the shares fell about 3.2% to €76.70 in pre-market trading after profit-taking; they had previously risen 57% since mid-September. Analysts rated the figures positively, and Jefferies expects a further upward revision of the full-year outlook. » Plus sur finanzen.net


  • Redcare Pharmacy beats forecasts with strong revenue and EBITDA growth

    In the third quarter Redcare Pharmacy’s revenue rose 18% to €847m, while adjusted EBITDA increased 68% to €28.7m, slightly above analyst expectations. The adjusted EBITDA margin was 3.4%; in the DACH region the margin improved year on year to 4.2%. The active customer base grew by 123,000 during the quarter, and management aims to further boost profitability through marketing optimisation and scale effects. Despite the positive numbers, the stock saw profit-taking. » Plus sur deraktionaer.de

Données financières de l'entreprise

Au dernier trimestre, Redcare Pharmacy a réalisé un chiffre d'affaires de 846,7 M € et un bénéfice net de 800 k €
(EUR) septembre 2026
YoY
Chiffre d'affaires 846,7 M 17,72 %
Bénéfice brut 184,6 M 16,18 %
Bénéfice net 800 k 111,05 %
EBITDA 28,3 M 72,67 %

Données fondamentales

Indicateur Valeur
Capitalisation boursière
1,19 Md €
Nombre d'actions
20,18 M
Plus haut/bas sur 52 semaines
69,94 € - 41,08 €
Dividendes Non
Bêta
1,63
Ratio P/E
-40,46
Ratio PEG
16,90
Ratio P/B
3,01
Ratio P/S
0,41

Profil de l'entreprise

Shop Apotheke Europe N.V. possède et exploite des pharmacies en ligne en Allemagne, en Autriche, en Suisse, en France, en Belgique, en Italie et aux Pays-Bas. Elle propose des médicaments sur ordonnance, des médicaments en vente libre, ainsi que des produits de beauté et de soins personnels liés à la pharmacie, de même que des compléments alimentaires. La société a été fondée en 2001 et son siège social se trouve à Sevenum, aux Pays-Bas.

Nom
Redcare Pharmacy
PDG
Peter Linstow
Siège social Sevenum, li
Pays-Bas
Site web
Secteur
Santé
Industrie
Prestataires et services de santé
Introduction en bourse
13/10/2016
Employés 1 827

Symboles boursiers

Bourse Symbole
München
SAE.MU
XETRA
SAE.DE
Düsseldorf
SAE.DU
Frankfurt
SAE.F
Hamburg
SAE.HM
London
0RJT.L
SIX
SAECHF.SW
Wien
SHOP.VI
Pnk
SHPPF
🍪

Parqet  utilise des cookies. En savoir plus